Nurse Practitioner in Groesbeck, TX Accepting Medicare

7 Nurse Practitioner nurses found. Showing 1 - 7

Mr. Dale E. Dyer, F.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 625 Mcclintic Dr, Groesbeck, TX 76642 Phone: 254-729-3411    Fax: 254-729-3258

Chelsea Annette Yerger, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 801 Mcclintic Dr, Groesbeck, TX 76642 Phone: 254-729-3411

Amy Oakes Silar, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 203 W Trinity, Groesbeck, TX 76642 Phone: 254-729-3740

Erin Holland, APRN Nurse Practitioner - Primary Care Medicare: Medicare Enrolled Practice Location: 701 Mcclintic Dr, Groesbeck, TX 76642 Phone: 254-729-3281

Susan R. Bond, RN, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 104 S Dr J B Riggs Dr, Groesbeck, TX 76642 Phone: 254-729-3356    Fax: 254-729-3489

Harmoni Suzanne Gallegos, CNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 204 W Trinity St, Groesbeck, TX 76642 Phone: 254-729-3740    Fax: 254-729-8760

Gayle Ann Hackbarth, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 701 Mcclintic Dr, Groesbeck, TX 76642 Phone: 254-729-3411    Fax: 254-729-3258

News Archive

Researchers design new app to help elderly patients reduce medication mistakes

The Calité Research group at the Miguel Hernández University of Elche together with the Department of Statistics, Mathematics and Computer Science, have designed the app 'Alicia'. The team collaborated with different Spanish medical centres and was coordinated by the Professor José Joaquín Mira. The aim of this application adapted to iPhone, iPad and Android, is to help patients over 65 years with multiple pathologies to administer their own medication at home.

Acceptance of initial regulatory filings for BMS-PCSK9Rx triggers $6M milestone payment to Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.

NHS staff concerns laid out in a report

Nearly one third of NHS staff say basic hygiene supplies such as hot water and soap are not always available when they need them. This was revealed in a comprehensive survey of the workforce. A third of workers said they would not be happy with the standard of care provided by their hospital if family or friends needed treatment, or had witnessed potentially dangerous errors in the past month. Many complained of bullying by colleagues and managers. Nearly 40% complained that low staffing levels prevented them from doing their jobs properly. The survey was completed by some 165,000 employees across England's 388 trusts. This is the eighth annual NHS Staff Survey, collated by the Care Quality Commission watchdog.

Viewpoints: Outrage at mistaken report on Hill health coverage; Two views of Florida's option on Medicaid

Because members of Congress are accustomed to high-quality medical care provided to them through federal employee benefit programs, one might expect that they would push for top quality care to be delivered through the exchanges too.

NIH launches new study to streamline COVID-19 treatments for larger clinical studies

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage clinical development show promise against COVID-19 and merit advancement into larger clinical trials.

Read more Medical News

› Verified 4 days ago